Featured Research

from universities, journals, and other organizations

New research may lead to a whole new class of vaccines

Date:
January 11, 2012
Source:
Trudeau Institute
Summary:
New research may lead to a whole new class of vaccines. Scientists have discovered new properties of a potential vaccine adjuvant that suggest it could be useful for enhancing protection against a number of different infections.

New research from the laboratory of Dr. Elizabeth Leadbetter at the Trudeau Institute may lead to a whole new class of vaccines. Dr. Leadbetter's lab has discovered new properties of a potential vaccine adjuvant that suggest it could be useful for enhancing protection against a number of different infections.

This new data will be published in the January 2012 issue of the journal Nature Immunology.

About the new findings

Effective vaccines train our bodies to recognize harmful microbes (such as viruses, bacteria and parasites) and typically contain disabled microbes, or even just components of microbes called antigens. Vaccination tricks our bodies into thinking we have been infected by the harmful microbe, triggering an immune response. Ideally, the vaccine produces a long-lived "memory" immune response to the microbe's antigens. This memory allows our bodies to respond more quickly and effectively if we ever become infected by the harmful microbe.

Most human vaccines contain adjuvants -- substances added to the vaccine to improve immune response to the antigens. Adjuvants increase the strength of the immune response and also allow for smaller amounts of antigens to be used in vaccine production.

Immune response to antigens results in the production of antibodies, which are a secreted product of B cells. Antibodies attach to antigens and help our bodies eliminate harmful microbes. Some T cells can help B cells make antibodies. Dr. Leadbetter previously discovered that natural killer T (NKT) cells, a special population of T cells, can help B cells make antibodies. NKT cells are special because they recognize lipid (fat) antigens. In contrast, most helper T cells recognize protein antigens. Because many harmful microbes produce unique lipids, Dr. Leadbetter hypothesized that directing NKT cells to help B cells could provide a new way to induce antibodies against harmful microbes, which would complement existing vaccine technologies.

Dr. Leadbetter's new studies advance her hypothesis that lipid molecules may serve as promising vaccine components. The studies demonstrate that NKT cells can help B cells produce antibodies that recognize lipids, but this does not result in long-lived memory immune responses to the lipid antigens. Second, the studies demonstrate that the lipids, when used as adjuvants to enhance immune responses to more conventional protein antigens, induce memory immune responses against the protein target without inducing a memory response to the lipid itself. Together, these findings suggest a single lipid adjuvant could be used multiple times without losing its effect. The new research also characterizes how NKT cells help B cells produce antibodies when lipids are used as a vaccine adjuvant.

Lipids may become an important new class of adjuvants not only because of their intrinsic properties but also because of their capacity to activate NKT cells. According to Dr. Leadbetter, "These cells are really fascinating because they have both innate and adaptive immune cell properties. In other words, they act rapidly, but also specifically. NKT cell activation by certain lipids enhances the activation of other immune cells, thus acting as the body's natural adjuvant."


Story Source:

The above story is based on materials provided by Trudeau Institute. Note: Materials may be edited for content and length.


Journal Reference:

  1. Irah L King, Anne Fortier, Michael Tighe, John Dibble, Gerald F M Watts, Natacha Veerapen, Ann M Haberman, Gurdyal S Besra, Markus Mohrs, Michael B Brenner, Elizabeth A Leadbetter. Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent manner. Nature Immunology, 2011; 13 (1): 44 DOI: 10.1038/ni.2172

Cite This Page:

Trudeau Institute. "New research may lead to a whole new class of vaccines." ScienceDaily. ScienceDaily, 11 January 2012. <www.sciencedaily.com/releases/2011/12/111212124610.htm>.
Trudeau Institute. (2012, January 11). New research may lead to a whole new class of vaccines. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2011/12/111212124610.htm
Trudeau Institute. "New research may lead to a whole new class of vaccines." ScienceDaily. www.sciencedaily.com/releases/2011/12/111212124610.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Nigeria Ups Ebola Stakes on 1st Death

Nigeria Ups Ebola Stakes on 1st Death

Reuters - Business Video Online (July 29, 2014) Nigerian authorities have shut and quarantined a Lagos hospital where a Liberian man died of the Ebola virus, the first recorded case of the highly-infectious disease in Africa's most populous economy. David Pollard reports Video provided by Reuters
Powered by NewsLook.com
Running 5 Minutes A Day Might Add Years To Your Life

Running 5 Minutes A Day Might Add Years To Your Life

Newsy (July 29, 2014) According to a new study, just five minutes of running or jogging a day could add years to your life. Video provided by Newsy
Powered by NewsLook.com
Ebola Outbreak Poses Little Threat To U.S.: CDC

Ebola Outbreak Poses Little Threat To U.S.: CDC

Newsy (July 29, 2014) The Ebola outbreak in West Africa poses little threat to Americans, according to officials with the Centers for Disease Control and Prevention. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins